Dae Gy Hong
Overview
Explore the profile of Dae Gy Hong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
492
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lee J, Hong D
Medicine (Baltimore)
. 2022 Oct;
101(40):e30977.
PMID: 36221377
Serum anti-Müllerian hormone (sAMH) is a useful marker of ovarian reserve. In many patients, the sAMH levels gradually recover after falling to the lowest level after surgery (nadir phenomenon). This...
12.
Lee J, Hong D
Anticancer Res
. 2022 Oct;
42(10):4937-4943.
PMID: 36191974
Background/aim: The influence of pleural effusion (PE) on survival outcomes in ovarian cancer has not been thoroughly evaluated. This study aimed to analyze the effect of pre-treatment PE on prognosis....
13.
Kim J, Hong D
Medicine (Baltimore)
. 2022 Sep;
101(35):e30105.
PMID: 36107548
Ovarian atypical endometriosis (AE) is a premalignant lesion, and its potential to progress to endometriosis-associated ovarian cancer emphasizes its significance. However, the true risk of malignancy in AE remains unclear....
14.
Lee J, Lee Y, Hong D
In Vivo
. 2022 Sep;
36(5):2409-2413.
PMID: 36099098
Background/aim: Short-term feasibility and safety of single-port total laparoscopic hysterectomy (TLH) compared with conventional multi-port TLH have been previously demonstrated. However, recent studies are insufficient. This study aimed to analyze...
15.
Park N, Park C, Jeong J, Kim M, Yoo S, Chong G, et al.
Diagnostics (Basel)
. 2022 Aug;
12(8).
PMID: 36010208
Infection with high-risk (HR) Human Papillomavirus (HPV) is associated with the development of precancerous lesions or invasive carcinoma of the uterine cervix. Thus, the high viral load (VL) of HR-HPV...
16.
Lee J, Hong D
Medicine (Baltimore)
. 2022 Aug;
101(32):e29967.
PMID: 35960085
In epithelial ovarian cancer, first-line adjuvant chemotherapy is necessary, and patients sometimes require protraction; however, there are only a few recent studies to show its influence. In this study, we...
17.
Lee J, Kim J, Lee Y, Chong G, Lee N, Lee I, et al.
In Vivo
. 2022 Jun;
36(4):1903-1910.
PMID: 35738605
Background/aim: Mutations of BRCA1/2 improve cancer prognosis due to their better response to platinum-based chemotherapy. This study evaluated overall survival (OS) and progression-free survival (PFS) under similar conditions of first-line...
18.
Lee J, Kim J, Lee Y, Chong G, Hong D
In Vivo
. 2022 Jun;
36(4):1868-1874.
PMID: 35738591
Background/aim: There have not been enough recent studies investigating the incidence or efficacy of dose reduction in adjuvant chemotherapy for epithelial ovarian cancer. This study examined whether patients who needed...
19.
Kim J, Chong G, Park N, Choi Y, Lee J, Lee Y, et al.
J Clin Med
. 2022 May;
11(9).
PMID: 35566784
Objective: Residual cancer cells (RCCs) contribute to cancer recurrence either because of tumor spillage or undetectable pre-existing micrometastatic tumor clones. We hypothesized that the pathologic evaluation of intraoperative peritoneal washes...
20.
Lee J, Kim J, Lee Y, Chong G, Hong D
Anticancer Res
. 2021 Dec;
42(1):349-353.
PMID: 34969744
Background/aim: To analyze the relationship between clinical outcomes for epithelial ovarian cancer and serum CA-125 levels after chemotherapy in Korean women. Patients And Methods: This study included 183 patients who...